In an interview, Andrew Kuykendall, MD, discussed fedratinib’s potential as an effective option for patients with ...

Medically reviewed by Doru Paul, MD Leukemia is a cancer of the blood-forming tissues that often develops in the bone marrow.

MSK experts believe that giving the targeted drug asciminib to patients with chronic myeloid leukemia at the beginning of ...

Fred Hutch is a world leader in leukemia research. Our laboratory, clinical and public-health research is improving the way the disease is diagnosed and treated, and improving the quality of life of ...

Now researchers explain why, by identifying specific changes in blood cells of people with Down ... Triplet Regimen Yields Promising Response in Advanced-Phase Chronic Myeloid Leukemia Sep. 17 ...

Researchers developed a computational model to optimize drug selection for chronic myelogenous leukemia (CML), tailoring ...

Which medicine is best when you are affected by cancer? This can vary from person to person. A new method can help people ...

Scientists at La Jolla Institute for Immunology (LJI) have discovered how a mutated gene kicks off a dangerous chain of ...

Dong adds that further research might also shine a light on the origins of some neurodevelopmental disorders. Other genes from the ASXL family can be mutated in neural stem cells, which may lead to ...

As humans age, we develop chronic inflammation in our blood and tissues that gradually decreases the function of blood stem ...